Velarion Records
Free. Unsubscribe any time.

NEKTAR THERAPEUTICS (NKTR)

NEKTAR THERAPEUTICS filed 8 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 23 transactions and 56,805 shares. 8 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in NEKTAR THERAPEUTICS 23

Adoption dates in NEKTAR THERAPEUTICS 2

Results prints in NEKTAR THERAPEUTICS 7

Trades before a print in NEKTAR THERAPEUTICS 0

Interval to NEKTAR THERAPEUTICS’s next reported results date

How the interval and sources are counted →

Adoption dates NEKTAR THERAPEUTICS states

Filing text: “10b5-1 trading plan adopted by the reporting person on May 16, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.